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Abstract
Introduction: A subpopulation of cancer cells, tumor-initiating cells, is believed to be the driving force behind 
tumorigenesis and resistance to radiation and chemotherapy. The persistence of tumor-initiating cells may depend on 
altered regulation of DNA damage and checkpoint proteins, as well as a reduced propensity to undergo apoptosis or 
senescence.
Methods: To test this hypothesis, we isolated CD24-/low/CD44+ tumor-initiating cells (as mammospheres) from MCF-7 
breast cancer cells grown in adherent monolayer culture, and carried out a comprehensive comparison of cell death 
and DNA damage response pathways prior to and after exposure to ionizing radiation in mammospheres and 
monolayer MCF-7 cells. Single and double-strand break repair was measured by single-cell gel electrophoresis. The 
latter was also examined by phosphorylation of histone H2AX and formation of 53BP1 and Rad51 foci. Apoptosis was 
quantified by flow-cytometric analysis of annexin V-binding and senescence was analyzed on the basis of cellular β-
galactosidase activity. We employed the telomeric repeat amplification protocol to quantify telomerase activity. 
Expression of key DNA repair and cell cycle regulatory proteins was detected and quantified by western blot analysis.
Results: Our data demonstrate that in comparison to the bulk population of MCF-7 cells (predominantly CD24+/
CD44+), the MCF-7 mammosphere cells benefit from a multifaceted approach to cellular protection relative to that 
seen in monolayer cells, including a reduced level of reactive oxygen species, a more active DNA single-strand break 
repair (SSBR) pathway, possibly due to a higher level of expression of the key SSBR protein, human AP endonuclease 1 
(Ape1), and a significantly reduced propensity to undergo senescence as a result of increased telomerase activity and a 
low level of p21 protein expression. No significant difference was seen in the rates of double-strand break repair (DSBR) 
between the two cell types, but DSBR in mammospheres appears to by-pass the need for H2AX phosphorylation.
Conclusions: Enhanced survival of MCF-7 tumor-initiating cells in response to ionizing radiation is primarily 
dependent on an inherent down-regulation of the senescence pathway. Since MCF-7 cells are representative of cancer 
cells that do not readily undergo apoptosis, consideration of senescence pathways may play a role in targeting stem 
cells from such tumors.
Introduction
Although considerable information has been amassed
concerning potential risk factors and the genetic back-
ground of breast cancer, the etiology of the disease is still
poorly understood [1]. Recent evidence led to the pro-
posal that normal stem cells may be the key cells in a tis-
sue or organ that undergo mutation and transformation
giving rise to 'cancer stem cells' [2-5]. As normal stem
cells are long-lived cells and the precursors to differenti-
ated cells, DNA repair and mutation avoidance in these
cells should be critical. Mutation and transformation of
normal stem cells are most likely the result of DNA dam-
age arising from exogenous and endogenous agents,
including oxidative free radicals and dietary and environ-
mental factors [6,7]. To counter such damage, cells pos-
sess a variety of multi-protein DNA repair pathways, each
responsible for handling a class of DNA lesions [8].
Until recently, evidence to support a direct role for an
altered DNA repair response in normal and cancer stem
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cells was limited and mostly confined to hematopoietic
cells [9-11]. A study of bone marrow-derived mesenchy-
mal stem cells, for example, identified a more efficient
reactive oxygen species (ROS) scavenging capacity in
these cells. Moreover, these stem cells exhibit active
homologous recombination (HR) and nonhomologous
end-joining (NHEJ) in the repair of double-stranded
breaks to facilitate their radio-resistance [11]. Data from
studies with murine embryonic stem cells indicate that
these cells efficiently repair DNA damage [12-14], and
that repair in embryonic stem cells may even be superior
to that in differentiated embryoid bodies or embryonic
fibroblasts [13]. The spontaneous mutation frequency in
murine embryonic stem cells is also significantly lower
than that in differentiated embryonic fibroblasts [15].
For cancer stem cells, mutation avoidance may be less
crucial, but cell survival should be a dominant character-
istic and may result in enhanced resistance to radiation
and chemotherapeutic agents [4,16]. Thus, there is a clear
need to identify the mechanisms that are involved in the
maintenance of genome stability and cell survival in can-
cer stem cells. It has proven extremely difficult to culture
sufficient numbers of stem cells from fresh solid tumor
m a t e r i a l  f o r  s u c h  s t u d i e s .  H o w e v e r ,  m a n y  e s t a b l i s h e d
tumor cell lines possess a small fraction of self-renewing
tumor-initiating (stem) cells that can form tumors from
very few cells [5,17-19]. Studies with such glioma [20] and
breast tumor-initiating cells [16,21,22], cultured as neu-
rospheres and mammospheres, respectively, have pro-
vided some insights. In both cases the stem cells were
observed to have elevated resistance to ionizing radiation,
and additional data indicated enhanced DNA damage
checkpoint activation [20] and repair capacity, as well as a
marked reduction in the measured level of ROS following
exposure to ionizing radiation [21], in comparison to the
monolayer cell populations from which the stem cells
were isolated.
To further explore the role of factors that safeguard
genomic integrity and cell survival, we carried out a
detailed comparison of single-strand break repair (SSBR)
and double-strand break repair (DSBR), telomerase activ-
ity, and cell death in MCF-7 breast cancer cells and
tumor-initiating cells isolated from the MCF-7 popula-
tion as mammospheres [21,23]. To date most attention
has focused on the apoptotic response of cancer stem
cells exposed to ionizing radiation and other cytotoxic
agents. Here we show for the first time that solid tumor
cancer cell 'stemness' can also influence the senescence
pathway.
Materials and methods
Cell culture and mammosphere preparation
The MCF-7 breast cancer cell line was obtained from the
American Type Culture Collection (Manassas, VA, USA).
The cells were cultured in 1:1 DMEM/nutrient mixture
F12 supplemented with 10% fetal bovine serum, 50 units/
ml penicillin, 50 μg/ml streptomycin, 2 mM L-glutamine,
0.1 mM nonessential amino acids and 1 mM sodium
pyruvate, all from Gibco/BRL-Invitrogen (Carlsbad, CA,
USA), and maintained at 37°C under 5% carbon dioxide
in a humidified incubator. When cells approached conflu-
ency, the supernatant was collected and plated on
ultralow attachment plates (Corning, Acton, MA, USA)
in serum-free medium supplemented with basic fibro-
blast growth factor (Millipore, Billerica, MA, USA), epi-
thelial growth factor and insulin (Sigma, St. Louis, MO,
USA) as described previously [23]. Mammospheres,
appearing as spheres of floating viable cells, were col-
lected by centrifugation and dissociated with 0.05%
trypsin followed by mechanical dissociation with a Pas-
teur pipette. Cells were then sieved sequentially through
a 100 μm and a 40 μm cell strainer (Falcon, San Jose, CA,
USA) and plated at low density.
Flow cytometry and cell cycle analysis
Purified mammospheres were characterized by analysis
of appropriate cell surface markers, CD24 and CD44, on a
Coulter Epics flow cytometer (Becton Dickinson, San
Jose, CA, USA). Briefly, 0.5 × 106 cells were mixed with
fluorescently-tagged antibodies to the surface antigens
(R-phycoerythrin-labelled anti-CD24 and fluorescein iso-
thiocyante-labelled anti-CD44 antibodies; BD Pharmin-
gen, San Diego, CA, USA) and incubated in the dark for
15 minutes at room temperature. Following incubation,
cells were washed with PBS containing 1% FCS, centri-
fuged for five minutes at 2,500 rpm. After aspiration,
approximately 50 μl of the cells were resuspended in PBS
containing 1% FCS and underwent fluorescence activated
cell sorter analysis immediately.
For cell cycle analysis, approximately 1 × 106 cells in an
aliquot of 1 ml were fixed by the addition of 3 ml cold
absolute ethanol. After one hour, cells were pelleted,
washed twice in PBS and treated with propidium iodide/
RNAse solution for 15 minutes at 37°C. Samples were
placed in 12 × 75 mm Falcon tubes and analysed by a
Coulter Epics flow cytometer.
Clonogenic cell survival assay
Stock cultures of MCF-7 monolayer and mammosphere
cells were trypsinized, resuspended in DMEM/F12
medium supplemented with 10% FCS, and plated in 60
mm tissue culture dishes at densities of 200 to 600 cells
per dish. The cells, as a single-cell suspension, were then
subjected to γ-radiation. After radiation, the cells were
allowed to adhere to the plates and incubated at 37°C for
18 days, after which they were fixed and stained with
crystal violet. Colonies consisting of 30 or more cells were
counted and the surviving fraction (in comparison toKarimi-Busheri et al. Breast Cancer Research 2010, 12:R31
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unirradiated controls) was plotted as a function of dose
using PRISM software (version 5.0 GraphPad, San Diego,
CA, USA)
Cell proliferation
Cellular survival of monolayer and mammospheres were
measured by cell proliferation assay using CellTiter 96
AQueous One Solution Cell Proliferation Assay (Pro-
mega, Madison, WI, USA). For this assay, both monolayer
and mammospheres were trypsinized and plated in a 96-
well plate at a density of 2 × 103 cells per well. Monolayer
cells were cultured in DMEM/F12 supplemented with
10% FCS and mammosphere media consisted of DMEM/
F12 supplemented with 0.4% fetal serum albumin, 20 ng/
ml basic fibroblast growth factor, 10 ng/ml epidermal
growth factor, 5 μg/ml bovine insulin, and 4 μg/ml hepa-
rin. The cells were then subjected to increasing doses of
γ- radiation (2 to 8 Gy) and incubated for five days at
37°C. Following incubation, 20 μl of CellTiter reagent
(Promega, Madison, WI, USA) was added per well and
after four hours of incubation at 37°C the absorbance was
recorded at 490 nm and plotted verses radiation doses.
All measurements were carried out in triplicate.
Detection of reactive oxygen species
For the detection of highly ROS we employed an amino-
phenyl fluorescein dye-based kit (Cell Technology Inc,
Mountain View, CA, USA) according to the manufac-
turer's protocol. Briefly, cells were rinsed in modified
Hank's balanced salt solution (10 mM 4-(2-hydroxy-
ethyl)piperazine -N'-(2-ethanesulfonic acid), 1 mM
MgCl2, 2 mM CaCl2, 2.7 mM glucose) and aminophenyl
fluorescein was added (to a final concentration of 10 μM)
to approximately 1.5 × 106 cells. Cells were incubated for
30 minutes in the dark and then exposed to 1, 4, or 10 Gy
γ-radiation (60Co Gammacell; Atomic Energy of Canada
Limited, Ottawa, Canada) and plated at 3 × 105 cells per
96-well plate. The fluorescence was immediately mea-
sured by excitation at 485 nm and reading emission at 515
nm using a fluorescence plate reader (Cell Technology
Inc., Columbia, MD, USA).
Single-cell gel electrophoresis (Comet assay)
At various times after irradiation of the cells, approxi-
mately 1 × 105 cells were trypsinized and mixed with 1.0
% molten low melting point agarose at 42°C at a 1:10 ratio
(10 μl cells per 100 μl of agarose). The mixture was then
spread on a glass slide (Trevigen, Gaithersburg, MD,
USA). Following solidification of the agarose, slides were
immersed in prechilled lysis solution (2.5 M NaCl, 100
mM Na2EDTA, pH 10, 10 mM Tris base, 1% SDS, 1% Tri-
ton X-100), followed by incubation on ice for 40 minutes
and immersion in an alkaline solution (300 mM NaOH, 1
mM Na2EDTA) for 30 minutes at room temperature.
Slides were then placed in an electrophoresis apparatus,
filled with fresh alkaline solution, and run at 1 V/cm and
approximately 300 mA at 4°C for 40 minutes. The slides
were washed in 70% ethanol for five minutes and the
DNA was stained with SYBR Green I (Molecular Probes-
Invitrogen, Carlsbad, CA, USA) and viewed with an
AxioScope 2 fluorescence microscope (Carl Zeiss,
Toronto, ON, Canada). For each data point we visualized
and analyzed a minimum of 100 random cell images
based on the 'comet' category shown by Collins [24]. (We
have changed the numbering 0 to 4 to 1 to 5).
For the neutral non-denaturing comet assay the cells
were lysed as described above followed by rinsing in 50
ml 1 × TBE (89 mM Tris base, 89 mM boric acid, 2 mM
EDTA) buffer. The slides were then subjected to electro-
phoresis at 1 volt/cm for 40 minutes in a horizontal elec-
trophoresis apparatus, followed by fixation in 70%
ethanol for five minutes and air dried. The slides were
then stained and scored as for alkaline comet.
Preparation of cell-free extract, immunoblotting, and 
immunostaining
For preparation of cell lysate we followed a previously
published method [25]. For western blotting and immu-
nohistochemistry standard protocols currently applied to
breast stem cells were used [26,27]. Antibodies to the fol-
lowing proteins were obtained commercially: PCNA
(monoclonal, sc-25280), XRCC1 (polyclonal, sc-11429),
Chk1 (polyclonal, sc-7898), Chk2 (polyclonal, sc-9064),
p21 (monoclonal, sc-6246), pRb (monoclonal, sc-103),
phospho-Chk1 (polyclonal, sc-17922R), Cdc25A (poly-
clonal, sc-7157), MDM2 (monoclonal, sc-5304), p53
(monoclonal, sc-126), E2F1 (monoclonal, sc-251), and
actin (polyclonal, sc-1616) from Santa Cruz Biotech
(Santa Cruz, CA, USA); ataxia telangiectasia mutated
(ATM; polyclonal, NB 100-104), apurinic/apyrimidinic
endonuclease 1 (APE1; monoclonal, NB 100-116) from
Novus Biologicals (Littleton, CO, USA); phospho-Chk2
(polyclonal, 2661), and phospho-p53 (sampler kit, #9919)
antibodies from Cell Signaling (Boston, MA, USA); phos-
pho-ATM (polyclonal, ab2888) and phospho-DNA-
dependent protein kinase catalytic subunit (DNA-PKcs;
polyclonal, ab18192) from Abcam (Cambridge, MA,
USA); PNK (monoclonal, MAB005) from CytoStore (Cal-
gary, AB, Canada); epithelial specific antigen (FITC-
labeled monoclonal, MM-1014) from Immunobiosci-
ences (Raleigh, NC, USA). Polyclonal anti-Ku80 antibody
was a gift from Dr. Susan Lees-Miller (University of Cal-
gary, Calgary, AB, Canada), antibody to polymerase-β
was a gift from Dr. Sam Wilson (National Institute of
Environmental Health Sciences, Research Triangle Park,
NC, USA), and monoclonal antibody to ING1 was kindly
provided by Dr. Karl Riabowol (University of Calgary,
Calgary, AB, Canada). Proteins on western blots wereKarimi-Busheri et al. Breast Cancer Research 2010, 12:R31
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visualized by enhanced chemiluminescence (Amersham
Pharmacia Biotech, Arlington Heights, IL, USA) and X-
Omat K film (Eastman Kodak Co., Rochester, NY, USA).
Films were scanned as image files and the optical densi-
ties of the bands were quantified using ImageJ software
version 1.33u (NIH, Bethesda, MA, USA).
Statistical analysis by two-tailed Student's t-test was
performed with Microsoft Excel software (Microsoft
Corp, Redmond, WA, USA).
For mammosphere immunostaining, we used a
Cytospin centrifuge (Thermo Shandon, Pittsburgh, PA,
USA) to prepare thin-layer mammospheres slides. Cells
were dried and fixed by paraformaldehyde. After blocking
with 5% milk powder, the Cytospin smears were stained
with appropriate primary and secondary antibodies.
Imaging of γH2AX, 53BP1 and Rad51 foci
We monitored the level of H2AX phosphorylation before
and after ionizing radiation by the modified protocol of
Furuta and colleagues [28]. Briefly, 1 × 105 MCF-7 cells
were seeded onto each glass coverslip inside 35 mm tissue
culture dishes. For mammospheres, however, we used a
Cytospin to prepare thin-layer mammosphere slides.
After incubation overnight at 37°C in a carbon dioxide
incubator, the cells were exposed to 1 or 10 Gy γ-radia-
tion and then incubated for different times at 37°C. The
cells were then fixed in 2% paraformaldehyde in PBS for
f i v e  m i n u t e s ,  f o l l o w e d  b y  w a s h e s  w i t h  P B S  a n d  5 0 : 5 0
methanol/PBS solution, and permeabilization with 100%
methanol for 20 minutes at -20°C. Cells were then
blocked with 5% milk powder at room temperature and
then exposed to a monoclonal antibody to anti-phospho-
histone H2AX (Ser-139) (Upstate, Charlottesville, VA,
USA) for one hour in the dark. After washing the cover-
slips with PBS, Alexa Fluor 488-labelled goat anti-mouse
secondary antibody (Molecular Probes-Invitrogen, Carls-
bad, CA, USA) was added to the coverslips and incubated
at room temperature for one hour in the dark. The cover-
slips were again washed twice with PBS and PBS/Tween
20 and finally rinsed with water. The coverslips were
mounted on a microscope slide using 95% glycerol in PBS
containing 3 μg/ml 4',6-diamidino-2-phenylindole. Slides
were stored at 4°C in the dark. Phosphorylated H2AX foci
were viewed with a LSM510 laser-scanning confocal
microscope (Carl Zeiss, Toronto, ON, Canada) mounted
on a Axiovert 100 M microscope (Carl Zeiss, Toronto,
ON, Canada). Images were taken with a ×40 (NA 1.3)
objective, following the Nyquist sampling requirement,
with the same instrument settings for different slides.
The average integrated intensity per nucleus was deter-
mined by using METAMORPH OFFLINE 6.1 software
(Universal Imaging, Downingtown, PA, USA), as
described previously [29].
The same procedure was followed to monitor 53BP1
and Rad51 foci. For the former we used an anti-53BP1
rabbit polyclonal antibody (ab36823) from Abcam (Cam-
bridge, MA, USA), and for the latter an anti-Rad51mouse
monoclonal antibody (ab213) from Abcam (Cambridge,
MA, USA).
Real-time quantitative RT-PCR
Total RNA was extracted from 2 × 106 cells using TRI-
ZOL Reagent (Invitrogen, Carlsbad, CA, USA) as per the
manufacturer's instructions. RNA concentration was
determined spectrophotometrically with a Life Science
UV/Vis Spectrophotometer (Beckman Coulter Du 730,
Brea, CA, USA).
The quantitative RT-PCR assay was performed on a
7900HT Real-Time PCR system (AB Applied Biosystem,
Carlsbad, CA, USA). Total RNA (0.5 μg) from each sam-
ple and standard was amplified using Platinum SYBR
Green quantitative PCR SuperMix-UDG (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer's pro-
tocol. The primer sequences for APE1 gene were 5'-GCT-
GCCTGGACTCTCTCATC-3' (sense), 5'-GCTGTT
ACCAGCACAAACGA-3' (antisense) to generate a 180
bp product. The primer sequences for ING1b were 5'-
CAACAACGAGAACCGTGAGA-3' (sense) and 5'-
GAGACCTGGTTGCACAGACA-3' (antisense) to give a
195 bp product. For GAPDH, as control, the primer
sequences were 5'-GTCTCCTCTGACTTCAACAGCG-
3' (sense) and 5'-ACCACCCTGTTGCTGTAGCCAA-3'
(antisense) to yield a 130 bp product. PCR conditions
were as follows: 50°C for 6 minutes, 95°C for 10 minutes
and 40 cycles of 95°C for 15 seconds and 60°C for 30 sec-
onds followed by 2 minutes incubation at 60°C. The cycle
threshold value for each gene was normalized by sub-
tracting the cycle threshold value of the GAPDH control
gene, and then the relative fold increase in transcript level
was calculated.
Telomerase assay
The telomerase assay was performed with a TRAPeze
Telomerase Detection kit (Chemicon, Temecula, CA,
USA) using non-radioactive detection. Whole cell
extracts were prepared from 106 unirradiated and irradi-
ated MCF-7 monolayer cells and 106 unirradiated and
irradiated mammosphere cells in CHAPS lysis buffer pro-
vided with the kit according to the manufacturer's
instruction. Samples of extract equivalent to 104  cells
were used in each assay. Following incubation with cell
extract and PCR amplification, the samples were ana-
lyzed by polyacrylamide gel electrophoresis and ethidium
bromide staining. The optical densities of the scanned
bands were quantified using ImageJ software version
1.33u (NIH, Bethesda, MD, USA). Statistical analysis byKarimi-Busheri et al. Breast Cancer Research 2010, 12:R31
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one-tailed Student's t-test was performed with Microsoft
Excel software (Microsoft Corp, Redmond, WA, USA).
Apoptosis and senescence-associated β-Gal assays
For the detection of apoptosis, unirradiated cells, or cells
exposed to 4 Gy γ-radiation (60Co Gammacell; Atomic
Energy of Canada Limited, Ottawa, Canada) three days
prior to collection, were harvested and analyzed by flow
cytometry for the induction of apoptosis using the BD
Pharmingen-Annexin V: FITC Apoptosis Detection Kit
(San Jose, CA, USA) according to the manufacturer's
instructions.
Induction of senescence was observed by morphologi-
cal changes detectable under light microscopy, and by
looking at cellular β-galactosidase activity [30], a known
marker of senescent cells, using a Senescence Galactosi-
dase Staining Kit (Cell Signaling, Beverly, MA, USA)
according to the manufacturer's protocol. As mammo-
spheres are non-adherent cells we used a Shandon
Cytospin centrifuge (Waltham, MA, USA) to spread cells
over the glass slides prior to fixation and staining.
Results
MCF-7 mammosphere isolation, radiation response and 
ROS content
Actively growing CD24-/low/CD44+ non-adherent mam-
mospheres were isolated from monolayer cultures of
MCF-7 breast cancer cells according to published proce-
dures [23], with some minor modifications [see Addi-
tional file 1]. We typically observed about 50% of
mammosphere cell population to have a CD24-/low/
CD44+ expression compared with less than 2% in the
monolayer cell population. We also examined expression
of epithelial specific antigen and, in agreement with Fill-
more and Kuperwasser [18], found the majority of both
the adherent population and mammospheres expressed
high levels of epithelial specific antigen (data not shown).
The mammosphere cell population was shown to be pre-
dominantly (about 80%) in G0/G1 with approximately
10% of cells in S and 10% in G2/M [see Additional file 2].
By comparison, the monolayer population was approxi-
mately 60% G0/G1, 25% S and 15% G2/M.
Phillips and colleagues [21] have previously shown that
the MCF-7 mammosphere population was less sensitive
to ionizing radiation than the monolayer cells. We
observed a similar radiation resistance in our preparation
of mammospheres based on measurement of cell survival
and cell proliferation (Figure 1). The colony-forming
assay used to monitor cell survival entailed irradiation of
both types of cells as single-cell suspensions, after which
the cells were allowed to adhere and cultured under iden-
tical conditions. For cell proliferation the monolayer cells
were grown under adherent conditions, while the mam-
mospheres remained in suspension after irradiation.
Cell death and mutation can result from exposure to
endogenous and exogenous oxidative agents that gener-
ate base damage and single-strand breaks and, less fre-
quently, double-strand breaks. We therefore measured
ROS in the mammospheres and monolayer cells both
before and after irradiation (Figure 2) and found a signifi-
cantly lower level of ROS in mammospheres, in agree-
ment with others [21]. In our study the reduced level of
ROS appears to be primarily attributable to lower pro-
duction of ROS in mammosphere cells rather than
increased neutralization, because cell irradiation
increased ROS by the same amount in both cell types.
Figure 1 Radiation response of MCF-7 monolayer and mammo-
spheres cells. (a) Clonogenic survival assay - MCF-7 monolayer and 
mammospheres were trypsinized, irradiated as single-cell suspensions 
with increasing doses of 60Co γ-radiation, and then plated. After18 days 
of incubation, the colonies (consisting of more than 30 cells) were 
fixed, stained with crystal violet and counted. (b) Cell proliferation as-
say - cells were plated in a 96-well plate, irradiated and incubated for 
five days. Cells were exposed to 3-(4,5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS, inner 
salt) for four hours and absorbance was measured at 490 nm. Absor-
bance was normalized to unirradiated controls. Error bars represent 
the mean ± standard error of the mean from three independent exper-
iments.
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Repair of radiation-induced strand breaks
The capacity to respond to ROS-induced DNA damage is
also a critical determinant in cell survival. A comparison
of SSBR, determined by single-cell gel electrophoresis
(comet assay) under alkaline conditions, indicated more
rapid repair at early times (two hours) in the CD24-/low/
CD44+ MCF-7 cells than the monolayer cells following
irradiation with 4 Gy (Figures 3a and 3b). The data are
similar to those obtained with glioma stem cells [20]. An
analysis of the expression of a panel of key SSBR proteins
(Figure 3c) indicated similar levels of expression between
mammospheres and monolayer cells with the notable
exception of APE1, which was expressed at an elevated
level (about two-fold) in unirradiated as well as irradiated
mammospheres (Table 1). APE1 cleaves DNA at abasic
sites and processes 3'-strand break termini, particularly
the removal of 3'-phosphoglycolate groups [31]. It is
required for mammalian cell survival and down-regula-
tion leads to the accumulation of abasic sites and apopto-
sis [32,33]. Real-time quantitative RT-PCR indicated an
approximately 10-fold increase (based on cycle threshold)
in APE mRNA in mammospheres than the monolayer
cells (data not shown), indicating that the increased
e x p r e s s i o n  o f  A P E 1  s ee n  i n  m a m m o s p h e r e s  i s  a t  l e a s t
partly regulated at the transcriptional level.
We next analyzed the rate of DSBR in the two cell types.
Initially, we attempted to monitor DSBR by following the
formation and disappearance of γ-H2AX foci. However,
unlike the MCF-7 monolayer cells, the mammospheres
failed to generate observable foci (Figure 4), an observa-
tion that concurs with Phillips and colleagues [21].
(These authors had used a flow cytometric approach to
monitor γ-H2AX, so we were keen to confirm their sur-
prising observation by more conventional cell imaging.
We also expanded the time of observation from the one-
hour post-irradiation time point chosen by Phillips and
colleagues to 0.25 to 16 hours post-irradiation). We
therefore followed double-strand break formation and
repair by single-cell gel electrophoresis under neutral
conditions, which indicated that as expected similar lev-
els of double-strand breaks are generated in the two cell
types and they are repaired at similar rates (Figures 5a
and 5b). Thus DSBR in mammospheres appears to bypass
the formation of γ-H2AX foci. Phosphorylation of H2AX
plays an important role in both NHEJ and HR repair
pathways, partly as a result of recruitment of other repair
proteins to the damaged sites, although it is dispensable
for initial damage recognition in NHEJ [34,35]. (As about
90% of the mammospheres were in G0/G1 and S-phase
cells the predominant DSBR pathway would be predicted
to be NHEJ). Furthermore, other DSBR pathways, such as
single-strand annealing [36] and an XRCC1/DNA ligase
III-dependent pathway [37], probably do not require
H2AX phosphorylation. However, evidence that mam-
mospheres, such as the monolayer cells, employ both
NHEJ and HR was indicated by the formation of radia-
tion-induced 53BP1 and Rad51 foci [see Additional file
3]. The former protein is principally associated with the
NHEJ pathway [38], while the latter is involved in HR
[39]. With both cell types, we observed a maximum in
53BP1 and Rad51 focus formation at two hours post-irra-
diation and a return to near background levels by 16
hours.
An examination of the expression of ATM and DNA-
PKcs, the kinases primarily responsible for the phospho-
rylation of histone H2AX [34], revealed differences
between the two cell types (Figure 5c). Firstly, unirradi-
ated and irradiated mammospheres expressed higher lev-
els of ATM (Table 1) and phospho-ATM (Ser1981)
following irradiation. Secondly, examination of activated
(phosphorylated) DNA-PKcs (phosphorylation at
Ser2056) indicated a considerable proportion of the
DNA-PKcs in the mammospheres appeared to have
undergone cleavage. Similar proteolysis of phosphory-
lated DNA-PKcs has previously been reported in cells
undergoing apoptosis [40] but, as discussed below, the
level of apoptosis in the unirradiated and irradiated
mammospheres was negligible. It is not known if the
cleaved phosphorylated DNA-PKcs acts in a dominant
negative fashion to inhibit phosphorylation of H2AX.
The level of expression of other NHEJ proteins examined,
Figure 2 Relative content of reactive oxygen species in unirradi-
ated and irradiated MCF-7 monolayer and mammosphere cells. 
Cells were incubated with aminophenyl fluorescein, exposed to 0, 1, 4 
or 10 Gy 60Co γ-radiation, and immediately afterwards the relative flu-
orescence of each sample was measured by excitation at 485 nm and 
emission at 515 nm. Error bars represent the mean ± standard error of 
the mean from three independent experiments.
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Ku80 and PNK, were not grossly different in the two cell
types (Figure 5c).
MCF-7 mammospheres display reduced cellular senescence
As the decreased level of ROS and more rapid SSBR
appeared unlikely to sufficiently account for the relative
radioresistance exhibited by mammospheres [21,22], we
went on to examine cell death pathways in the MCF-7
populations, paying particular attention to cellular senes-
cence because MCF-7 cells are not prone to apoptosis
due to a lack of caspase-3 activation [41]. Replicative
senescence is considered a process triggered by telomere
shortening that limits the lifespan of normal cells, but it
may also serve as a block to tumorigenesis in premalig-
nant cells [42]. Ionizing radiation and similar cytotoxic
agents can induce stress-induced premature or acceler-
ated senescence in normal and tumor cell lines [43,44].
Telomerase, which is expressed in stem cells and in can-
cer cells [45], maintains telomere length, thereby prevent-
ing replicative senescence. The enzyme may also protect
against premature or accelerated senescence by protect-
ing chromosome ends from nucleolytic degradation
[46,47]. Using the Telomeric Repeat Amplification Proto-
col to measure telomerase activity in monolayer and
mammosphere cells (Figure 6a), we observed that both
cell types displayed telomerase activity, which increased
after irradiation with 1 and 10 Gy. Telomerase activity is
revealed by the presence of the extended oligonucleotides
Table 1: Relative expression of DNA repair and cell cycle proteins in MCF-7 monolayer and mammosphere populations
Protein Dose(Gy) Normalized band intensity (n = 3) P value
Monolayer Mammosphere
APE1 0 1.00 2.10 0.024
1 1.02 1.92 0.052
10 1.07 1.84 0.017
ATM 0 1.00 1.99 0.018
1 1.13 2.23 0.011
10 1.62 1.99 0.088
p21 0 1.00 0.04 0.001
1 1.16 1.04 0.207
10 1.17 1.11 0.310
Chk1 0 1.00 2.17 0.003
1 1.03 2.06 0.018
10 1.05 2.31 0.052
phospho-Chk1 0 1.00 0.92 0.116
1 1.13 0.80 0.027
10 1.08 0.85 0.006
Chk2 0 1.00 2.39 0.001
1 0.92 2.46 0.001
10 0.93 2.51 0.005
phospho-Chk2 0 1.00 0.69 0.034
1 0.91 0.64 0.030
10 0.84 0.91 0.180
APE1, apurinic/apyrimidinic endonuclease 1; ATM, ataxia telangiectasia mutated; phospho-Chk1, Chk1 phosphorylated at Ser345; phospho-
Chk2, Chk2 phosphorylated at Thr68.Karimi-Busheri et al. Breast Cancer Research 2010, 12:R31
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Figure 3 Analysis of single strand break repair in MCF-7 monolayer and mammosphere cell populations. (a) Cells were exposed to 4 Gy 60Co 
γ-radiation and the relative degree of single-strand breakage (SSB) was determined by alkaline single-cell gel electrophoresis (comet assay) immedi-
ately after exposure and at the times indicated after exposure. (b) The 'comets' (n of about 100) were categorized according to the NIH LISTSERV (Com-
et Assay Interest Group web site) in which type 1 comets display the least DNA damage and type 5 the most. The error bars represent the mean ± 
standard error of the mean in both panels. The comets of the unirradiated cells are labeled Cont. (c) Expression of proteins involved in SSB repair in 
response to ionizing radiation. Lysates were prepared from unirradiated cells and from cells harvested one hour after exposure to 1 or 10-Gy 60Co γ-
radiation and analyzed by immunoblotting with antibodies against several SSB repair proteins. α-Actin served as a loading control.
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migrating slower than the 36 bp primer. However, the
telomerase activity in the mammospheres was statisti-
cally significantly more robust than in the monolayer
population (Figure 6b).
An examination of other key proteins involved in the
regulation of senescence revealed that the mammosphere
cells, in comparison to the monolayer cell population,
expressed markedly lower levels of the senescence signal-
ing protein, p21, especially in unirradiated cells (Figure
7a). In the case of pRb there was a notable reduction in
total protein following irradiation with 1 Gy and also a
lower degree of phosphorylation after 10-Gy irradiation
of the mammospheres. Inactivation of p21 and pRb is
required to prevent senescence [48], and indeed analysis
of senescence based on cellular β-galactosidase activity
revealed that the percentage of senescent mammospheres
is approximately half that of the monolayer population
both prior to irradiation and three days after irradiation
with 4 Gy (Figure 7b). As p21 is associated with telomere
shortening and replicative senescence, it is perhaps not
surprising that its expression is negligible in the unirradi-
ated stem cell population. pRb, on the other hand, has
been shown to regulate stress-induced senescent arrest in
a p16-dependent pathway. However, in agreement with
others [49] we found that MCF-7 cells fail to express p16.
Additional confirmation of the reduced tendency of the
mammospheres to undergo senescence was provided by
an analysis of the expression of ING1. Elevated expres-
sion of this tumor suppressor protein is strongly associ-
ated with increased replicative senescence [50]. Although
there was no marked response to the radiation, it is clear
from Figure 7c that the MCF-7 monolayer cells display a
more than five-fold higher (P < 0.003) level of ING1 pro-
tein than the mammosphere cells. The enhanced level of
ING1 protein was not reflected by an increased level of
transcription as measured by quantitative RT-PCR (data
not shown), suggesting that the protein in the monolayer
cells may be stabilized or undergo slower turnover. The
only ING1 isoform detected in these cells was ING1b.
Interestingly, loss of expression of ING1b in breast
tumors has been found to be associated with more poorly
differentiated tumors and therefore may be indicative of
poor prognosis [51].
We also observed a smaller percentage of apoptotic/
necrotic cells (based on annexin V-FITC binding) in the
unirradiated mammosphere population, despite the
cleavage of DNA-PKcs, than in monolayer populations
(2.8 vs 5.3%). Little difference was observed in these num-
bers after irradiation (data not shown) presumably
because MCF-7 cells do not readily undergo apoptosis
[41].
Expression of DNA damage/cell cycle response proteins
In light of our data indicating reduced expression levels of
p21 and reduced phosphorylation of H2AX and pRb in
mammospheres, we probed the status of other proteins
involved in cell cycle and cell death responses to oxidative
stress (Figure 8) downstream of ATM. The signal media-
tors, Chk1 and Chk2, reveal a similar pattern of expres-
sion and modification. In both cases, the level of total
protein was higher in the unirradiated and irradiated
mammospheres than monolayer cells, but the degree of
phosphorylation (Chk1 Ser345 and Chk2 Thr68) was
considerably lower. Phosphorylated Chk2, in turn, desta-
bilizes Cdc25A by phosphorylation and targeting it for
ubiquitination [52]. Consistent with a lower level of phos-
phorylated Chk2 in mammospheres, we observed a more
pronounced signal for Cdc25A in these cells. On the
other hand, Chk2 stabilizes E2F1 by phosphorylation of
the latter protein [53]. We found mammospheres to con-
tain moderately less E2F1 than the monolayer cells.
Expression of p53 in the MCF-7 monolayer population
in response to irradiation followed the anticipated pat-
tern, that is there was a dose-dependent increase in pro-
tein accumulation with elevated phosphorylation of
serines 9 and 15. In the mammospheres, however,
although the level of p53 in the unirradiated cells was
higher than in the monolayer population, there was no
clearly discernable increase in p53 in response to irradia-
tion with 1 or 10 Gy. Furthermore, p53 in the unirradi-
ated mammospheres was shown to be more highly
phosphorylated at serines 9 and 15, and again this did not
alter markedly with dose. Thus not only does the phos-
Figure 4 Radiation induced H2AX phosphorylation in MCF-7 
monolayer and mammosphere cells. (a) Unirradiated cells or cells 
exposed to 1 or 10 Gy γ-radiation and then incubated for one hour at 
37°C, or (b) cells exposed to 1 Gy and incubated at 37°C for different 
times, were fixed, permeabilized and immunostained with an antibody 
to γH2AX and counter-stained with 4',6-diamidino-2-phenylindole 
(DAPI). H2AX phosphorylation was clearly visible as characteristic fluo-
rescent foci in the irradiated monolayer cells, but no foci were detect-
able in the irradiated mammosphere cells.
M
o
n
o
l
a
y
e
r
M
a
m
m
o
s
p
h
e
r
e
0 1 10        Gy (after 1 hour repair)
M
a
m
m
o
s
p
h
e
r
e
0.25 h repair     1 h repair        16 h repair    1 Gy
(a)
(b)Karimi-Busheri et al. Breast Cancer Research 2010, 12:R31
http://breast-cancer-research.com/content/12/3/R31
Page 10 of 16
Figure 5 Analysis of double strand break repair in MCF-7 monolayer and mammosphere populations. (a) Cells were exposed to 4 Gy 60Co γ-
radiation and the relative degree of double-strand breakage (DSB) was determined by the comet assay under neutral conditions immediately after 
exposure and at the times indicated after exposure. (b) The 'comets' (n of about 100) were categorized according to the NIH LISTSERV (Comet Assay 
Interest Group web site) in which type 1 comets display the least DNA damage and type 5 the most. The error bars represent the mean ± standard 
error of the mean in both panels. The comets of the unirradiated cells are labeled Cont. (c) Expression of proteins involved in the NHEJ pathway of 
DSB repair in response to increasing doses of ionizing radiation. Lysates were prepared from unirradiated cells and from cells harvested one hour after 
exposure to 1 or 10-Gy 60Co γ-radiation and analyzed by immunoblotting with antibodies against several DSB repair proteins. Phospho-ATM and phos-
pho-DNA-PKcs refer to phosphorylation of these proteins at Ser1981 and Ser2056, respectively. Actin served as a loading control.
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Figure 6 Telomerase activity in MCF-7 monolayer and mammosphere cells. (a) Telemorase activity was determined by Telomeric Repeat Ampli-
fication Protocol (TRAP) analysis. Cell extracts were prepared from unirradiated and irradiated MCF-7 monolayer and mammospheres cells. The assay 
involves the addition, mediated by telomerase in the cell extract, of a number of telomeric repeats onto the 3' end of an oligonucleotide substrate, 
which is then subjected to amplification by PCR. When run on a 10 to 12% native polyacrylamide gel, the telomerase-extended primer appears as a 
ladder of 6 bp increments. The lowest band on the gel shows the 36 bp internal PCR control. (The absence of this band in the lane showing results 
with 10-Gy irradiated mammospheres is due to excessively high telomerase activity because amplification of the TRAP products and the internal con-
trol is semi-competitive.) The positive (+ve) control lane shows the results using a telomerase positive cell extract provided by the manufacturer of 
the assay kit, while a cell extract prepared from human fibroblasts (CRL 2322) served as a negative control. (b) Quantification of telomerase activity. 
The mean values and standard deviations were calculated from three individual determinations at each dose. The difference in activity between the 
monolayer and mammosphere populations at each dose were statistically significant (P < 0.05, Student's t-test).
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phorylation of p53 differ between the two cell types, but
in addition the phosphorylation of p53 differs from the
phosphorylation of H2AX, Chk1 and Chk2, despite their
potential dependence on ATM. It suggests that either
ATM preferentially phosphorylates p53 or that the levels
of phosphorylation may reflect the relative activities of
phosphatases such as Wip1 known to dephosphorylate
Chk2 at Thr68 in a p53-dependent manner and act in a
negative feedback loop between the two proteins [54].
Intriguingly, the pattern of p53 expression and phospho-
rylation in mammospheres and monolayer cells bears a
resemblance to recent findings with p21-/- and wild type
HCT116 colon cancer cells [55], that is high constitutive
expression of p53 (and Chk2) and elevated phosphoryla-
tion of Ser15 in the untreated p21-/- cells and no change
in either expression or phosphorylation in response to
oxidative damage induced by chromium.
Discussion
The data presented here demonstrate that mammo-
spheres, as a representative of epithelial mammary cancer
progenitors, are distinct from their differentiated MCF-7
cells. It has been previously shown by others that MCF-7
mammospheres are more resistant to ionizing radiation
than the monolayer cells and have lower ROS content in
unirradiated and irradiated cells [21,22], and we have cor-
roborated their findings. Phillips and colleagues [21] also
ascertained that the observed effects were not the result
of differences in the growth factor content of the media in
which the two cell types were cultured. In our laboratory,
the clonogenic survival assays of the two cell types was
carried out under identical growth conditions post-irra-
diation while the cell proliferation assays were carried out
under the respective optimal growth conditions for the
two cell types. That both assays showed the radio-resis-
tance of the mammosphere cells further supports the idea
that this reflects the intrinsic radiosensitivity of the cells
rather than an artifact of the culture conditions.
We have now established several other facets of the
response of mammospheres to endogenously and exoge-
nously induced DNA damage. It is clear that mammo-
spheres possess efficient base excision repair/SSBR,
p r o b a b l y  m e d i a t e d  b y  a n  e l e v a t e d  l e v e l  o f  A P E 1 .
Although base excision and SSBR are largely responsible
for cellular protection from endogenous oxidative dam-
age, they also play a role in response to radiation and anti-
neoplastic agents. For example, in breast cancer patients
receiving the radiomimetic drug, anthracycline, lower
APE1 expression was associated with a better pathologic
response [56]. We also observed that mammospheres
exhibit a similar DSBR response after irradiation as the
monolayer cells in spite of the lack of H2AX phosphory-
lation, implying that mammospheres use a γH2AX-inde-
pendent pathway for DSBR. The formation of 53BP1 and
Rad51 foci in the irradiated mammospheres strongly sug-
gests that both the NHEJ and HR pathways can be initi-
ated, although further study will be required to fully
elucidate the DSBR pathway utilization by these cells.
In terms of radiation-induced cell death, the most
important pathway for MCF-7 cells appears to be replica-
tive senescence but the mammospheres displayed a
markedly reduced tendency to undergo senescence. The
immediate molecular basis for the senescent behaviour
can be attributed to the robust telomerase activity and
negligible p21 expression. However, p21 expression is
regulated by ATM through Chk2 and p53 [57], and thus
Figure 7 Senescence-related factors in MCF-7 monolayer and 
mammosphere populations. (a) Expression of key proteins involved 
in the cellular senescence pathway in response to increasing doses of 
ionizing radiation. Lysates were prepared from unirradiated cells and 
from cells harvested one hour after exposure to 1 or 10-Gy 60Co γ-radi-
ation and analyzed by immunoblotting with antibodies against p21 
and pRb. ppRb indicates phosphorylated pRb. Actin served as a load-
ing control. (b) Senescence was measured in unirradiated (control) 
cells and irradiated (4 Gy, 3 days post-irradiation) MCF-7 monolayer 
and mammosphere cells by staining for β-galactosidase activity. Cells 
(n of more than 100) were counted independently by two individuals. 
The error bars represent the mean ± standard error of the mean. (c) Ex-
pression of ING1 protein. Lysates were prepared as described for Fig-
ure 6a. Western blots were performed with a mixture of four 
monoclonal antibodies against a domain common to ING1a, ING1b 
and ING1c. Based on the apparent molecular weight of the observed 
band (about 35 kDa), the protein was identified as ING1b.
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Figure 8 Expression of DNA damage/cell cycle response proteins in unirradiated and irradiated MCF-7 cells. (a) Lysates were prepared from 
unirradiated monolayer and mammosphere cells and from cells harvested one hour after exposure to 1 or 10-Gy 60Co γ-radiation and analyzed by 
immunoblotting. Phospho-Chk1 and phospho-Chk2 indicate phosphorylation of Chk1 and Chk2 at Ser345 and Thr68, respectively. Actin served as a 
loading control. (b) Phosphorylation of p53 at various amino acids. Phosphorylation at serines 6, 9, 37, 46, and 392 was negative (data not shown).
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implicit in our findings is that reduced Chk2 phosphory-
lation/activation may play a significant role in the senes-
cence phenotype of MCF-7 mammospheres.
Finally, it is to be anticipated that cellular pathways uti-
lized by cancer stem cells to enhance survival will depend
on the genetic background of the stem cells. For example,
MCF-7 cells are representative of cancer cells that do not
readily undergo apoptosis, and thus enhanced survival of
MCF-7 cancer-initiating cells is primarily dependent on
down-regulation of the senescence pathway. A similar
response may be expected in other cancer stem cells,
such as those with inactivating mutations in the proline-
rich domain of p53, which is required for p53-dependent
transactivation of key apoptotic genes but not p21
[58,59]. On the other hand, avoidance of apoptosis is
likely to play a more critical role in the survival response
exhibited by cancer stem cells that possess potential func-
tional apoptotic activity. This may explain the differences
in DNA repair/cell cycle protein expression and post-
translational modification seen between the current
study and Bao and colleagues [20].
Conclusions
MCF-7 CD24-/low/CD44+ tumor-initiating cells, grown as
mammospheres, have previously been shown to be more
resistant to ionizing radiation than the general popula-
tion of MCF-7 adherent cells. We have carried out a com-
prehensive comparison of the DNA damage/cell cycle
and cell death responses of the two cell types. Enhanced
survival of MCF-7 tumor-initiating cells in response to
ionizing radiation is primarily dependent on an inherent
down-regulation of the senescence pathway, which can be
attributed to elevated telomerase activity as well as
reduced p21 expression and pRb phosphorylation. Our
data highlight the need to consider targeting proteins that
regulate senescence in tumor-initiating cells, especially in
tumor cells such as MCF-7 that do not readily undergo
apoptosis.
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